» Articles » PMID: 28650151

Orthogonal Comparison of GC-MS and H NMR Spectroscopy for Short Chain Fatty Acid Quantitation

Overview
Journal Anal Chem
Specialty Chemistry
Date 2017 Jun 27
PMID 28650151
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Short chain fatty acids (SCFAs) are important regulators of host physiology and metabolism and may contribute to obesity and associated metabolic diseases. Interest in SCFAs has increased in part due to the recognized importance of how production of SCFAs by the microbiota may signal to the host. Therefore, reliable, reproducible, and affordable methods for SCFA profiling are required for accurate identification and quantitation. In the current study, four different methods for SCFA (acetic acid, propionic acid, and butyric acid) extraction and quantitation were compared using two independent platforms including gas chromatography coupled with mass spectrometry (GC-MS) and H nuclear magnetic resonance (NMR) spectroscopy. Sensitivity, recovery, repeatability, matrix effect, and validation using mouse fecal samples were determined across all methods. The GC-MS propyl esterification method exhibited superior sensitivity for acetic acid and butyric acid measurement (LOD < 0.01 μg mL, LOQ < 0.1 μg mL) and recovery accuracy (99.4%-108.3% recovery rate for 100 μg mL SCFA mixed standard spike in and 97.8%-101.8% recovery rate for 250 μg mL SCFAs mixed standard spike in). NMR methods by either quantitation relative to an internal standard or quantitation using a calibration curve yielded better repeatability and minimal matrix effects compared to GC-MS methods. All methods generated good calibration curve linearity (R > 0.99) and comparable measurement of fecal SCFA concentration. Lastly, these methods were used to quantitate fecal SCFAs obtained from conventionally raised (CONV-R) and germ free (GF) mice. Results from global metabolomic analysis of feces generated by H NMR and bomb calorimetry were used to further validate these approaches.

Citing Articles

Probiotic Mixture Attenuates Colorectal Tumorigenesis in Murine AOM/DSS Model by Suppressing STAT3, Inducing Apoptotic p53 and Modulating Gut Microbiota.

Leung H, Lo E, Chen C, Zhang F, Felicianna , Ismaiah M Probiotics Antimicrob Proteins. 2024; .

PMID: 39641861 DOI: 10.1007/s12602-024-10405-1.


Reconstituting gut microbiota-colonocyte interactions reverses diet-induced cognitive deficits: The beneficial of polysaccharides.

Wang M, Sun P, Chai X, Liu Y, Li L, Zheng W Theranostics. 2024; 14(12):4622-4642.

PMID: 39239516 PMC: 11373620. DOI: 10.7150/thno.99468.


Short-Chain Fatty Acids and Preeclampsia: A Scoping Review.

Zhao H, Chen Y, Liu T, McArthur K, Mueller N Nutr Rev. 2024; 83(2):e683-e693.

PMID: 38796843 PMC: 11723139. DOI: 10.1093/nutrit/nuae057.


Probiotic Mixture Ameliorates a Diet-Induced MASLD/MASH Murine Model through the Regulation of Hepatic Lipid Metabolism and the Gut Microbiome.

Zhang F, Lo E, Chen J, Wang K, Felicianna , Ismaiah M J Agric Food Chem. 2024; 72(15):8536-8549.

PMID: 38575146 PMC: 11037262. DOI: 10.1021/acs.jafc.3c08910.


Rapid quantification of 50 fatty acids in small amounts of biological samples for population molecular phenotyping.

Liu P, Chen Q, Zhang L, Ren C, Shi B, Zhang J Biophys Rep. 2024; 9(6):299-308.

PMID: 38524698 PMC: 10960574. DOI: 10.52601/bpr.2023.230042.


References
1.
Singh V, Chassaing B, Zhang L, Yeoh B, Xiao X, Kumar M . Microbiota-Dependent Hepatic Lipogenesis Mediated by Stearoyl CoA Desaturase 1 (SCD1) Promotes Metabolic Syndrome in TLR5-Deficient Mice. Cell Metab. 2015; 22(6):983-96. PMC: 4670569. DOI: 10.1016/j.cmet.2015.09.028. View

2.
Vernia P, BREUER R, Gnaedinger A, Latella G, Santoro M . Composition of fecal water. Comparison of "in vitro" dialysis with ultrafiltration. Gastroenterology. 1984; 86(6):1557-61. View

3.
Frankel W, Lew J, Su B, Bain A, Klurfeld D, Einhorn E . Butyrate increases colonocyte protein synthesis in ulcerative colitis. J Surg Res. 1994; 57(1):210-4. DOI: 10.1006/jsre.1994.1133. View

4.
Cai J, Zhang L, Jones R, Correll J, Hatzakis E, Smith P . Antioxidant Drug Tempol Promotes Functional Metabolic Changes in the Gut Microbiota. J Proteome Res. 2015; 15(2):563-71. PMC: 4847541. DOI: 10.1021/acs.jproteome.5b00957. View

5.
Weitkunat K, Schumann S, Nickel D, Kappo K, Petzke K, Kipp A . Importance of propionate for the repression of hepatic lipogenesis and improvement of insulin sensitivity in high-fat diet-induced obesity. Mol Nutr Food Res. 2016; 60(12):2611-2621. PMC: 5215627. DOI: 10.1002/mnfr.201600305. View